Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pater

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials GroupC M Coppin, M K Gospodarowicz, K James, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III TrialD Warr, A Wilan, P Venner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapyJ Rusthoven, J Pater, L Kaizer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2006
A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20E Chow, P J Hoskin, J Wu, et al.
American Journal of Clinical Oncology|December 1, 1992
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancerB Weinerman, A Shah, A Fields, et al.
Seminars in Oncology|September 1, 1986
The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancerW K Evans, R Feld, N Murray, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 12, 2003
Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative studyM Brundage, A Leis, A Bezjak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Communicating quality of life information to cancer patients: a study of six presentation formatsM Brundage, D Feldman-Stewart, A Leis, et al.
Journal of Clinical Immunology|April 1, 1982
Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicityH F Pross, J Pater, I Dwosh, et al.
Archives of Internal Medicine|June 1, 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patientsR Feld, T J Louie, L Mandell, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials GroupC M Coppin, M K Gospodarowicz, K James, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III TrialD Warr, A Wilan, P Venner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1991
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapyJ Rusthoven, J Pater, L Kaizer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 10, 2006
A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20E Chow, P J Hoskin, J Wu, et al.
American Journal of Clinical Oncology|December 1, 1992
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancerB Weinerman, A Shah, A Fields, et al.
Seminars in Oncology|September 1, 1986
The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancerW K Evans, R Feld, N Murray, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 12, 2003
Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative studyM Brundage, A Leis, A Bezjak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Communicating quality of life information to cancer patients: a study of six presentation formatsM Brundage, D Feldman-Stewart, A Leis, et al.
Journal of Clinical Immunology|April 1, 1982
Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicityH F Pross, J Pater, I Dwosh, et al.
Archives of Internal Medicine|June 1, 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patientsR Feld, T J Louie, L Mandell, et al.
Pageof 8